Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
87.8M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
-405K
-
Total reported value, excl. options
-
$3.5M
-
Value change
-
-$132K
-
Number of buys
-
17
-
Number of sells
-
-16
-
Price
-
$0.31
Significant Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q2 2025
56 filings reported holding CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q2 2025.
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
of 87.8M outstanding shares and own 12.78% of the company stock.
Largest 10 shareholders include BIOS Capital Management, LP (6M shares), VANGUARD GROUP INC (1.3M shares), ACADIAN ASSET MANAGEMENT LLC (702K shares), Chescapmanager LLC (503K shares), Voss Capital, LP (450K shares), GEODE CAPITAL MANAGEMENT, LLC (369K shares), CM Management, LLC (250K shares), AMERICAN FINANCIAL GROUP INC (205K shares), Kestra Advisory Services, LLC (156K shares), and Sigma Planning Corp (148K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.